These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 2245691)
1. Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock. Danner RL; Natanson C; Elin RJ; Hosseini JM; Banks S; MacVittie TJ; Parrillo JE Chest; 1990 Dec; 98(6):1480-7. PubMed ID: 2245691 [TBL] [Abstract][Full Text] [Related]
2. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. Natanson C; Danner RL; Elin RJ; Hosseini JM; Peart KW; Banks SM; MacVittie TJ; Walker RI; Parrillo JE J Clin Invest; 1989 Jan; 83(1):243-51. PubMed ID: 2642920 [TBL] [Abstract][Full Text] [Related]
3. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. Natanson C; Eichenholz PW; Danner RL; Eichacker PQ; Hoffman WD; Kuo GC; Banks SM; MacVittie TJ; Parrillo JE J Exp Med; 1989 Mar; 169(3):823-32. PubMed ID: 2647895 [TBL] [Abstract][Full Text] [Related]
4. Role of endotoxemia in cardiovascular dysfunction and lethality: virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock. Hoffman WD; Danner RL; Quezado ZM; Banks SM; Elin RJ; Hosseini JM; Natanson C Infect Immun; 1996 Feb; 64(2):406-12. PubMed ID: 8550184 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular performance with E. coli challenges in a canine model of human sepsis. Natanson C; Danner RL; Fink MP; MacVittie TJ; Walker RI; Conklin JJ; Parrillo JE Am J Physiol; 1988 Mar; 254(3 Pt 2):H558-69. PubMed ID: 3279822 [TBL] [Abstract][Full Text] [Related]
6. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. Natanson C; Fink MP; Ballantyne HK; MacVittie TJ; Conklin JJ; Parrillo JE J Clin Invest; 1986 Jul; 78(1):259-70. PubMed ID: 3722379 [TBL] [Abstract][Full Text] [Related]
7. Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock. Freeman BD; Yatsiv I; Natanson C; Solomon MA; Quezado ZM; Danner RL; Banks SM; Hoffman WD J Am Coll Surg; 1995 Mar; 180(3):286-92. PubMed ID: 7874338 [TBL] [Abstract][Full Text] [Related]
8. Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. Eichacker PQ; Waisman Y; Natanson C; Farese A; Hoffman WD; Banks SM; MacVittie TJ J Appl Physiol (1985); 1994 Nov; 77(5):2366-73. PubMed ID: 7532649 [TBL] [Abstract][Full Text] [Related]
9. The cardiocirculatory and metabolic effects of endotoxin challenge after canine resuscitated hemorrhagic shock. Horton J J Trauma; 1989 Feb; 29(2):195-202. PubMed ID: 2563778 [TBL] [Abstract][Full Text] [Related]
10. Elevated plasma vasopressin concentrations during endotoxin and E. coli shock. Wilson MF; Brackett DJ; Tompkins P; Benjamin B; Archer LT; Hinshaw LB Adv Shock Res; 1981; 6():15-26. PubMed ID: 6760706 [TBL] [Abstract][Full Text] [Related]
11. Contribution of peripheral blood pooling to central hemodynamic disturbances during endotoxin insult in intact dogs. D'Orio V; Wahlen C; Naldi M; Fossion A; Juchmes J; Marcelle R Crit Care Med; 1989 Dec; 17(12):1314-9. PubMed ID: 2686936 [TBL] [Abstract][Full Text] [Related]
12. The cardiovascular response of normal humans to the administration of endotoxin. Suffredini AF; Fromm RE; Parker MM; Brenner M; Kovacs JA; Wesley RA; Parrillo JE N Engl J Med; 1989 Aug; 321(5):280-7. PubMed ID: 2664516 [TBL] [Abstract][Full Text] [Related]
13. Cardiorespiratory effects of Pseudomonas and E. coli endotoxins in the awake dog. Miller TH; Priano LL; Jorgensen JH; Traber DL Am J Physiol; 1977 Jun; 232(6):H682-9. PubMed ID: 406796 [TBL] [Abstract][Full Text] [Related]
14. Serial measures of total body oxygen consumption in an awake canine model of septic shock. Eichacker PQ; Hoffman WD; Danner RL; Banks SM; Richmond S; Fitz Y; Natanson C Am J Respir Crit Care Med; 1996 Jul; 154(1):68-75. PubMed ID: 8680702 [TBL] [Abstract][Full Text] [Related]
15. Plasma endotoxin concentration in healthy primates and during E. coli-induced shock. Wessels BC; Wells MT; Gaffin SL; Brock-Utne JG; Gathiram P; Hinshaw LB Crit Care Med; 1988 Jun; 16(6):601-5. PubMed ID: 3286118 [TBL] [Abstract][Full Text] [Related]
16. A new canine model of endotoxin shock. Evans SF; Hinds CJ; Varley JG Br J Pharmacol; 1984 Oct; 83(2):433-42. PubMed ID: 6435710 [TBL] [Abstract][Full Text] [Related]
17. Role of angiotensin I and glucagon in canine endotoxin shock: effect of converting enzyme inhibitor and prior immunization. Manson NH; Hess ML Circ Shock; 1984; 12(3):177-89. PubMed ID: 6325034 [TBL] [Abstract][Full Text] [Related]
18. The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure. Quezado ZM; Hoffman WD; Winkelstein JA; Yatsiv I; Koev CA; Cork LC; Elin RJ; Eichacker PQ; Natanson C J Exp Med; 1994 Feb; 179(2):569-78. PubMed ID: 8294868 [TBL] [Abstract][Full Text] [Related]
19. Augmented venous return: a model of left ventricular afterload reduction during the course of endotoxin shock. Hess ML; Krause SM; Komwatana P; Eaton R; Okabe E Circ Shock; 1981; 8(4):435-50. PubMed ID: 7023737 [TBL] [Abstract][Full Text] [Related]